OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价胺受体激动剂临床应疗效性。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价胺受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴呆小鼠脑海马5-羟色胺(5-HT)和胺(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是种类似
胺的
胺激动剂,
代
胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其
胺D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目观察当归芍药散对血管性痴呆小鼠脑海马5-羟色
(5-HT)和多
(DA)含量
影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多多
激动剂,与第一代多
激动剂不同
是没有麦角林结构。罗匹尼罗
非麦角林结构可以说明其与多
D2受体有较高
结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴胺受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴呆小鼠脑海马5-羟色胺(5-HT)和多巴胺(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
匹
一种类似多巴胺的多巴胺激动剂,与第一代多巴胺激动剂不同的
没有麦角林结构。
匹
的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。
声明:以上例句、词性分类均由互网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价受体激
临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴呆小鼠脑海马5-羟色(5-HT)和多
(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是种类似多
的多
激
,
第
代多
激
不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其
多
D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴胺受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴脑海马5-羟色胺(5-HT)和多巴胺(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多巴胺的多巴胺激动剂,与第一代多巴胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴胺受剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴呆小鼠脑海马5-羟色胺(5-HT)和多巴胺(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多巴胺的多巴胺剂,与第一代多巴胺
剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受
有较高的结合力。
声明:以上例句、词性分类均由互联网资源自生成,部分未
过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴胺受体激动应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴呆小鼠海马5-羟色胺(5-HT)和多巴胺(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多巴胺的多巴胺激动,与第一代多巴胺激动
不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴胺受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目的观察当归芍药散对血管性痴呆小鼠脑海马5-羟色胺(5-HT)和多巴胺(DA)含量的影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
是一种类似多巴胺的多巴胺激动剂,与第一代多巴胺激动剂不同的是没有麦角林结构。
的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。
声明:以上例句、词性分类均由互网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴胺受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要察当归芍药散对血管性痴呆小鼠脑海马5-羟色胺(5-HT)和多巴胺(DA)含量
影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多巴胺多巴胺激动剂,与第一代多巴胺激动剂不同
是没有麦角林结构。罗匹尼罗
非麦角林结构可以说明其与多巴胺D2受体有较高
结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件点;若发现问题,欢迎向我们指正。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价受体激动剂临床应疗效性。
Objective: To observe the effect of Dangguishaoyao Powder on Hydroxytryptamine 5 (5-HT) and dopamine (DA) of vascular dementia mice.
摘要目观察当归芍药散对血管性痴呆小鼠脑海马5-羟色
(5-HT)和多
(DA)含量
影响。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多多
激动剂,与第一代多
激动剂不同
是没有麦角林结构。罗匹尼罗
非麦角林结构可以说明其与多
D2受体有较高
结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。